FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for Oxybutynin from Zydus Pharmaceuticals USA Inc., indicating an updated approval for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

SUPPL AP for OXYBUTYNIN (OXYBUTYNIN)